Cargando…
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment
Background. The elderly, commonly defined as subjects aged ≥65 years, are among the at-risk subjects recommended for annual influenza vaccination in European countries. Currently, two new vaccines are available for this population: the MF59-adjuvanted quadrivalent influenza vaccine (aQIV) and the hi...
Autores principales: | Calabrò, Giovanna Elisa, Boccalini, Sara, Panatto, Donatella, Rizzo, Caterina, Di Pietro, Maria Luisa, Abreha, Fasika Molla, Ajelli, Marco, Amicizia, Daniela, Bechini, Angela, Giacchetta, Irene, Lai, Piero Luigi, Merler, Stefano, Primieri, Chiara, Trentini, Filippo, Violi, Sara, Bonanni, Paolo, de Waure, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998177/ https://www.ncbi.nlm.nih.gov/pubmed/35409848 http://dx.doi.org/10.3390/ijerph19074166 |
Ejemplares similares
-
L’Health Technology Assessment come strumento
value-based per la valutazione delle tecnologie sanitarie.
Reassessment del vaccino antinfluenzale quadrivalente da
coltura cellulare: Flucelvax Tetra(®) 2.0
por: CALABRÒ, GIOVANNA ELISA, et al.
Publicado: (2023) -
Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population
por: Capri, Stefano, et al.
Publicado: (2018) -
Strengthening the Evidence-Based Approach to Guiding Effective Influenza Vaccination Policies
por: Calabrò, Giovanna Elisa, et al.
Publicado: (2020) -
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment
por: de Waure, Chiara, et al.
Publicado: (2019) -
The burden of seasonal influenza in Italy: A systematic review of influenza‐related complications, hospitalizations, and mortality
por: Giacchetta, Irene, et al.
Publicado: (2021)